Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Clinical trial NCT01522820 · COMPLETED

Trial details

NCT number: NCT01522820
Sponsor: Roswell Park Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anaplastic Astrocytoma Anaplastic Oligoastrocytoma Anaplastic Oligodendroglioma Estrogen Receptor Negative Estrogen Receptor Positive Glioblastoma Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma Metastatic Renal Cell Cancer Recurrent Adult Brain Neoplasm Recurrent Bladder Carcinoma Recurrent Breast Carcinoma

Start date: 2012-03-01
Primary completion: 2016-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.